AIPRI
AIPRI
ACE Inhibition in Progressive Renal Insufficiency. A clinical trial assessing the safety and efficacy of benazepril in protecting residual renal function in patients with various types of renal failure.Conclusion Actuarial survival probability was significantly better at 3 years with benazepril, especially in patients with glomerular disease, idiopathic renal failure, and diabetic nephropathy.